Pharmaceutical company Moderna intends to apply Monday to the US Food and Drug Administration ( FDA ) for authorization of its Covid 19 vaccine . 
The company will ask the FDA to review an expanded data set showing the vaccine is 94.1 % effective at preventing Covid 19 and 100 % effective at preventing severe cases of the disease . 
One other company , Pfizer , has already applied for FDA authorization for a coronavirus vaccine , with efficacy data very similar to Moderna ’s results . 
The FDA is expected to review both companies ’ applications in December , and Anthony Fauci , director of the National Institute for Allergy and Infectious Diseases , said he expects the first vaccinations in the US to occur " towards the latter part of December . " 
By the end of 2020 , Moderna expects to have approximately 20 million doses of its vaccine available in the United States , and it ’s on track to manufacture 500 million to 1 billion doses globally next year , according to the company ’s news release Monday . 
